FDA proposes to modernize guidance on sex, gender in clinical trials

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesClinical TrialsGuidanceMedical DevicesPharmaceuticalsUnited StatesUS Food and Drug Administration (FDA)